While the impact of the highly polymorphic NAT2 locus on the pharmacokinetics of INH has long been recognized, there are relatively few data on the distribution of NAT2 alleles in patients with tuberculosis in Latin America [23–25]. The gene discussed is NAT2; the disease is tuberculosis.